Chandan Healthcare IPO Subscribed Over 5 Times So Far On Final Day; Check GMP, Allotment Date And More
Diagnostic centres-operator Chandan Healthcare Ltd. has branches in North India, offering pathology and radiology testing services.
The initial public offering of Chandan Healthcare Ltd. has been subscribed over five times on the last and final day of bidding on Wednesday. The SME IPO, launched on Feb. 10, aims to raise Rs 107.36 crore from investors in the primary markets.
Chandan Healthcare IPO was subscribed 0.19 times on the opening day on Monday while it was booked 0.8 times on Tuesday. The bidding for Chandan Healthcare IPO will close in a few hours. Check out these key details:
Chandan Healthcare IPO: All You Need To Know
Bidding dates: Feb. 10 to Feb. 12
Price range: Rs 151 to Rs 159
Minimum investment: Rs 1,20,800
IPO size: Rs 107.36 crore
Allotment date: Feb. 13
Listing date: Feb. 17
Registrar: Kfin Technologies Ltd.
Chandan Healthcare IPO Day 3 Subscription Status
Chandan Healthcare IPO has been subscribed 5.61 times as of 3:10 p.m. on Wednesday, as per market tracking site Chittorgarh:
Qualified Institutional Buyers: 4.15 times
Non-Institutional Investors: 17.49 times
Retail Investors: 1.98 times
*The subscription status will be updated at regular intervals.
Chandan Healthcare IPO GMP Today
Chandan Healthcare IPO GMP fell to Rs 3 apiece from Rs 8 on Wednesday. According to InvestorGain, this indicates a listing gain of 1.89%, with the shares expected to debut on NSE SME at Rs 162 apiece given that the current trends are sustained.
Note: GMP or grey market price is not an official price quote for the stock and is based on speculation.
Chandan Healthcare: Company Details
Diagnostic centres-operator Chandan Healthcare Ltd. has branches in North India, offering pathology and radiology testing services.
The company operated one flagship laboratory, seven central laboratories, and 26 satellite centres as of Dec. 31, 2024. It also has over 300 collection centres in 40-plus cities across Uttar Pradesh and Uttarakhand. Its subsidiary, Chandan Pharmacy, runs medical stores offering pharmaceutical products.
The company will use portions of the fresh proceeds from the IPO to set up a flagship diagnostic centre in Lucknow, and two laboratories each in Ayodhya and Lucknow. The rest of the proceeds will be used for general corporate purposes.
Disclaimer: Investments in initial public offerings are subject to market risks. Please consult with financial advisors and read red herring prospectus thoroughly before placing bids.
